← Back to Search

Behavioural Intervention

CBT vs Mindfulness-Based Therapy for Autism

N/A
Recruiting
Led By Brenna Maddox, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥18 years of age
Co-occurring depression and/or anxiety as determined by a score ≥10 on the PHQ-ADS depression and/or anxiety subscale
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6-months follow-up
Awards & highlights

Study Summary

This trial will compare CBT & MBT, two treatments for depression & anxiety in autistic adults, to see which is more effective.

Who is the study for?
This trial is for English-speaking autistic adults over 18 living in North Carolina or Virginia. Participants must have a professional autism diagnosis or score high on an autism screening, and show signs of depression or anxiety. Those with acute mental issues, intoxication, mania, or at risk of suicide cannot join.Check my eligibility
What is being tested?
The study compares Cognitive-Behavioral Therapy (CBT) and Mindfulness-Based Cognitive Therapy (MBCT) to see which is more effective for treating depression and anxiety in autistic adults. Both therapies will be given through telehealth sessions.See study design
What are the potential side effects?
While CBT and MBCT are generally safe, some may experience increased anxiety, emotional discomfort during sessions, fatigue after therapy work, or frustration if expected improvements aren't seen.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have depression or anxiety with a score of 10 or more on the PHQ-ADS.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6-months follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6-months follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety and depression symptoms
Secondary outcome measures
Change in disability
Change in functional impairment
Change in mental health
+7 more

Trial Design

2Treatment groups
Active Control
Group I: Cognitive-Behavioral Therapy (CBT)Active Control1 Intervention
The arm receives the Unified Protocol (UP), a modular transdiagnostic CBT treatment that uses a parsimonious approach to treatment by addressing common emotion-related mechanisms underlying both anxiety and depression.
Group II: Mindfulness-Based Cognitive Therapy (MBCT)Active Control1 Intervention
Mindfulness-Based Cognitive Therapy (MBCT) is an empirically supported treatment that focuses on non-judgmental acceptance of present moment experiences and emotions. MBCT was adapted from Mindfulness-Based Stress Reduction (MBSR) to focus on improving mental health more specifically in individuals with depression and other psychiatric conditions.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,508 Previous Clinical Trials
4,190,742 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
551 Previous Clinical Trials
29,997,158 Total Patients Enrolled
University of VirginiaOTHER
754 Previous Clinical Trials
1,244,773 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this experiment still available?

"The details recorded on clinicaltrials.gov indicate that this trial, which went online October 15th 2023 and was last updated September 22nd 2023, is no longer accepting new participants. Fortunately, 1716 other research studies are currently recruiting patients at present."

Answered by AI

Who else is applying?

What site did they apply to?
University of Virginia
What portion of applicants met pre-screening criteria?
Met criteria
~200 spots leftby Jul 2025